BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38176734)

  • 21. Conformational plasticity and allosteric communication networks explain Shelterin protein TPP1 binding to human telomerase.
    Aureli S; Cardenas VB; Raniolo S; Limongelli V
    Commun Chem; 2023 Nov; 6(1):242. PubMed ID: 37935941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex interaction network revealed by mutation of human telomerase 'insertion in fingers' and essential N-terminal domains and the telomere protein TPP1.
    Lambert-Lanteigne P; Young A; Autexier C
    J Biol Chem; 2023 Mar; 299(3):102916. PubMed ID: 36649908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo stoichiometry of shelterin components.
    Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
    J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of active human telomerase with telomere shelterin protein TPP1.
    Liu B; He Y; Wang Y; Song H; Zhou ZH; Feigon J
    Nature; 2022 Apr; 604(7906):578-583. PubMed ID: 35418675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structurally conserved TELR region on shelterin protein TPP1 is essential for telomerase processivity but not recruitment.
    Sandhu R; Sharma M; Wei D; Xu L
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34282008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NEK6-mediated phosphorylation of human TPP1 regulates telomere length through telomerase recruitment.
    Hirai Y; Tamura M; Otani J; Ishikawa F
    Genes Cells; 2016 Aug; 21(8):874-89. PubMed ID: 27396482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline.
    Graniel JV; Bisht K; Friedman A; White J; Perkey E; Vanderbeck A; Moroz A; Carrington LJ; Brandstadter JD; Allen F; Shami AN; Thomas P; Crayton A; Manzor M; Mychalowych A; Chase J; Hammoud SS; Keegan CE; Maillard I; Nandakumar J
    Life Sci Alliance; 2022 Jan; 5(1):. PubMed ID: 34645668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of telomere biology disorders.
    Grill S; Nandakumar J
    J Biol Chem; 2021; 296():100064. PubMed ID: 33482595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic peptides of human TPP1 fulfill diverse functions in telomere maintenance.
    Rajavel M; Orban T; Xu M; Hernandez-Sanchez W; de la Fuente M; Palczewski K; Taylor DJ
    Nucleic Acids Res; 2016 Dec; 44(21):10467-10479. PubMed ID: 27655633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UV light-induced dual promoter mutations dismantle the telomeric guardrails in melanoma.
    Sanford SL; Opresko PL
    DNA Repair (Amst); 2023 Feb; 122():103446. PubMed ID: 36603239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biallelic TERT variant leads to Hoyeraal-Hreidarsson syndrome with additional dyskeratosis congenita findings.
    Çepni E; Satkın NB; Moheb LA; Rocha ME; Kayserili H
    Am J Med Genet A; 2022 Apr; 188(4):1226-1232. PubMed ID: 34890115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional analysis of the human POT1-TPP1 telomeric complex.
    Rice C; Shastrula PK; Kossenkov AV; Hills R; Baird DM; Showe LC; Doukov T; Janicki S; Skordalakes E
    Nat Commun; 2017 Apr; 8():14928. PubMed ID: 28393830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
    Zhu J; Liu W; Chen C; Zhang H; Yue D; Li C; Zhang L; Gao L; Huo Y; Liu C; Giaccone G; Zhang B; Wang C
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1509-1519. PubMed ID: 31016380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human telomere POT1-TPP1 complex and its role in telomerase activity regulation.
    Wang F; Lei M
    Methods Mol Biol; 2011; 735():173-87. PubMed ID: 21461822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple facets of TPP1 in telomere maintenance.
    Rajavel M; Mullins MR; Taylor DJ
    Biochim Biophys Acta; 2014 Sep; 1844(9):1550-9. PubMed ID: 24780581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7.
    Zemp I; Lingner J
    J Biol Chem; 2014 Oct; 289(41):28595-606. PubMed ID: 25172512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TPP1 mutagenesis screens unravel shelterin interfaces and functions in hematopoiesis.
    Grill S; Padmanaban S; Friedman A; Perkey E; Allen F; Tesmer VM; Chase J; Khoriaty R; Keegan CE; Maillard I; Nandakumar J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33822766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. POT1-TPP1 telomere length regulation and disease.
    Aramburu T; Plucinsky S; Skordalakes E
    Comput Struct Biotechnol J; 2020; 18():1939-1946. PubMed ID: 32774788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of telomerase recruitment and cancer cell death.
    Nakashima M; Nandakumar J; Sullivan KD; Espinosa JM; Cech TR
    J Biol Chem; 2013 Nov; 288(46):33171-80. PubMed ID: 24097987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of human telomerase recruitment by TPP1-POT1.
    Sekne Z; Ghanim GE; van Roon AM; Nguyen THD
    Science; 2022 Mar; 375(6585):1173-1176. PubMed ID: 35201900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.